Intermittent High-Dose Glucocorticoid Treatment Does Not Cause Adrenal Insufficiency in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study
Acta Haematologica · 2024
DOI: 10.1159/000534317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica, 2024. Verfasst von Margret Jona Einarsdottir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Adrenal Insufficiency, Lymphoma, Large B-Cell, Diffuse, Glucocorticoids, Cosyntropin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glucocorticoid (GC) treatment suppresses the hypothalamic-pituitary-adrenal axis and can cause GC-induced adrenal insufficiency. In this study, we investigated the incidence of GC-induced adrenal insufficiency in patients receiving intermittent short-term high-dose oral GC treatment for newly diagnosed diffuse large B-cell lymphoma. Cosyntropin stimulation test was used to assess adrenal function at study entry (baseline), at 2 months (before the 5th cycle), and 6 months from baseline (3 months after the last cycle). Ten patients were included (40% women). Mean age was 61 years. The mean (range) plasma morning cortisol was 407 (320–530) nmol/L at baseline, 373 (260–610) nmol/L at 2 months, and 372 (230–520) nmol/L at 6 months from baseline. All patients had normal response to cosyntropin stimulation at baseline as well as 2 and 6 months from baseline. Thus, none of the patients developed biochemically verified adrenal insufficiency. Therefore, short-term high-dose GC therapy, a commonly used adjuvant treatment in patients with malignant hematological diseases, does not seem to down-regulate the hypothalamic-pituitary-adrenal axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Wallenberg Center for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
Zitieren
APA
Einarsdottir, M. J., Kristjansdottir, H. L., Bergthorsdottir, R., Johannsson, G., Trimpou, P., Lewerin, C., & Ragnarsson, O. (2024). Intermittent High-Dose Glucocorticoid Treatment Does Not Cause Adrenal Insufficiency in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study. Acta Haematologica. https://doi.org/10.1159/000534317
Vancouver
Einarsdottir MJ, Kristjansdottir HL, Bergthorsdottir R, Johannsson G, Trimpou P, Lewerin C, et al. Intermittent High-Dose Glucocorticoid Treatment Does Not Cause Adrenal Insufficiency in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study. Acta Haematologica. 2024. doi:10.1159/000534317
BibTeX
@article{Einarsdottir2024,
author = {Einarsdottir, Margret Jona and Kristjansdottir, Hallgerdur L and Bergthorsdottir, Ragnhildur and Johannsson, Gudmundur and Trimpou, Penelope and Lewerin, Catharina and Ragnarsson, Oskar},
title = {Intermittent High-Dose Glucocorticoid Treatment Does Not Cause Adrenal Insufficiency in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study},
journal = {Acta Haematologica},
year = {2024},
doi = {10.1159/000534317}
}
EUVIMED